Found 0 matching trials
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase III Trial of Remestemcel-L-rknd Added to Ruxolitinib for Grade III-IV Steroid-Refractory Acute Graft-Versus-Host Disease PHASE3 This study is a randomized, double-blind, placebo-controlled, multicenter P...
Show More Location
Multiple Locations
Learn More & Join Trial
Prochymal Expanded Access Treatment for Pediatric Patients Who Have Failed Steroids for Acute GVHD N/A This protocol allows for the treatment of pediatric patients, male and fema...
Show More Status
No Longer Available
Location
Phoenix Children's Hospital
Learn More & Join Trial
Prochymal™ Adult Human Mesenchymal Stem Cells for Treatment of Moderate-to-severe Crohn's Disease PHASE2 Human mesenchymal stem cells (MSCs), derived from healthy adult volunteer h...
Show More Location
Osiris Clinical Site
Learn More & Join Trial
Prochymal® (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI) PHASE2 The objective of the present study is to establish the safety and efficacy ...
Show More Location
Mercy Gilbert Medical Center / Catholic Health Care West
Learn More & Join Trial
PROCHYMAL® (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM) PHASE2 The purpose of this study is to establish the safety and efficacy of multip...
Show More Location
University of Alabama, Division of Endocrinology & Metabolism
Learn More & Join Trial
Efficacy and Safety of Prochymal® Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD) PHASE3 This is a Phase III, randomized, double-blind, placebo-controlled study to ...
Show More Location
University of Alabama Birmingham (UAB) Hospital
Learn More & Join Trial
Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute Graft Versus Host Disease (GVHD) PHASE2 To establish the safety and efficacy of two dose levels of ex-vivo cultured...
Show More Location
St. Francis Hospital
Learn More & Join Trial
Evaluation of PROCHYMAL® for Treatment-refractory Moderate-to-severe Crohn's Disease PHASE3 To provide open-label re-treatment with PROCHYMAL to participants enrolled ...
Show More Location
University of California, San Francisco
Learn More & Join Trial
Study of Mesenchymal Stem Cells for the Treatment of Medically Refractory Crohn's Colitis PHASE1 Crohn's disease has several phenotypes (inflammatory, stricturing, fistuliz...
Show More Learn More & Join Trial
Evaluation of PROCHYMAL® Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease PHASE3 Protocol 603 is enrolling subjects with moderate-to-severe Crohn's disease ...
Show More Location
University of Southern California University Hospital
Learn More & Join Trial